Actinogen Medical Ltd (acw) Logo

Actinogen Medical Ltd (ACW)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News

ACW ASX Chart

Snapshot

Actinogen Medical Limited (ACW, formerly Actinogen Limited) is an ASX-listed biotechnology company developing innovative treatments for Alzheimer's disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases, like Type 2 diabetes. It focusses on the development of Xanamem, a novel treatment for Alzheimer's disease and the cognitive deficiency associated with other neurological and metabolic diseases within Australia.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2023 YTD
1 Year
vs Sector (1yr) -67.49%
vs ASX 200 (1yr) -75.85%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,136 of 2,403
Sector Rank 92 of 219

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies SPL / AHC / AHX
EPS -$0.006
DPS $0.00
Book Value Per Share $0.005

Broker Consensus

ACW is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Latest Actinogen Medical Ltd News

More News

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Sydney NSW 2000
Website -
Registry Automic Group
Auditor Ernst & Young
Date Listed -

Upcoming Calendar (Forecasted)

Date Event
21/02/2024 Report (Interim)
28/08/2024 Report (Prelim)
28/08/2024 Report (Annual)
11/10/2024 Report (Annual)

Former Company Names

  • Actinogen Limited (ACW), 17/11/2015

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

ACW directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
27/11/23 George Morstyn Expiry 1,500,000 $0.023 $34,500 Options expired
27/11/23 Geoffrey Brooke Expiry 4,900,000 $0.023 $112,700 Options expired
11/09/23 Malcolm McComas Issued 401,372 $0.025 $10,034 Rights issue
11/09/23 Malcolm McComas Issued 200,687 $0.022 $4,415 Rights issue
11/09/23 George Morstyn Issued 614,537 $0.025 $15,363 Rights issue
11/09/23 George Morstyn Issued 599,610 $0.025 $14,990 Rights issue
11/09/23 George Morstyn Issued 607,074 $0.022 $13,355 Rights issue
11/09/23 Steven Gourlay Issued 1,405,727 $0.025 $35,143 Rights issue
11/09/23 Steven Gourlay Issued 3,479,565 $0.025 $86,989 Rights issue
11/09/23 Steven Gourlay Issued 2,442,647 $0.022 $53,738 Rights issue
11/09/23 Geoffrey Brooke Issued 550,661 $0.025 $13,766 Rights issue
11/09/23 Geoffrey Brooke Issued 474,058 $0.025 $11,851 Rights issue
11/09/23 Geoffrey Brooke Issued 512,360 $0.022 $11,271 Rights issue
11/11/22 George Morstyn Buy +1,500,000 $0.100 $150,000 Exercise of options
11/11/22 George Morstyn Exercise 1,500,000 $0.100 $150,000 Exercise of options
03/11/22 Steven Gourlay Buy +750,000 $0.125 $93,507 On-market trade
20/05/22 Geoffrey Brooke Buy +340,000 $0.075 $25,362 On-market trade
12/05/22 Steven Gourlay Buy +2,000,000 $0.064 $128,240 On-market trade
06/04/22 Steven Gourlay Issued 797,222 $0.135 $107,624 Placement
20/12/21 Malcolm McComas Issued 222,223 $0.135 $30,000 Participation in share purchase plan
20/12/21 George Morstyn Issued 222,223 $0.135 $30,000 Participation in share purchase plan
20/12/21 Geoffrey Brooke Issued 222,223 $0.135 $30,000 Participation in share purchase plan
18/11/21 Geoffrey Brooke Issued 2,500,000 $0.200 $500,000 Issued under employee share plan
18/11/21 George Morstyn Issued 1,000,000 $0.200 $200,000 Issued under employee share plan
18/11/21 Malcolm McComas Issued 1,000,000 $0.200 $200,000 Issued under employee share plan
17/11/20 Malcolm McComas Issued 100,000 $0.022 $2,200 Rights issue
17/11/20 George Morstyn Issued 40,000 $0.022 $880 Rights issue
17/11/20 John (Bill) Ketelbey Issued 1,862,182 $0.022 $40,968 Rights issue
17/11/20 John (Bill) Ketelbey Issued 128,579 $0.022 $2,828 Rights issue
17/11/20 Geoffrey Brooke Issued 265,000 $0.022 $5,830 Rights issue
31/01/20 John (Bill) Ketelbey Cancelled 3,000,000 $0.035 $105,000 Cancellation of securities
22/11/19 John (Bill) Ketelbey Transfer 9,000,000 $0.050 $450,000 As advised by the company
22/11/19 John (Bill) Ketelbey Transfer 9,000,000 $0.050 $450,000 As advised by the company
12/04/19 Malcolm McComas Issued 3,000,000 $0.052 $156,000 Issue of options
13/12/18 Geoffrey Brooke Issued 4,900,000 $0.048 $235,200 Issue of options
13/12/18 John (Bill) Ketelbey Issued 11,700,000 $0.048 $561,600 Issue of options
13/07/18 Geoffrey Brooke Issued 300,000 $0.050 $15,000 Participation in share purchase plan
13/07/18 John (Bill) Ketelbey Issued 300,000 $0.050 $15,000 Participation in share purchase plan
01/06/18 George Morstyn Buy +200,000 $0.051 $10,282 On-market trade
22/01/18 Geoffrey Brooke Issued 625,000 $0.040 $25,000 Placement
21/12/17 Geoffrey Brooke Issued 53,333 $0.044 $2,347 Issue of options
21/12/17 Jason Loveridge Issued 3,716,677 $0.044 $163,534 Issue of options
21/12/17 John (Bill) Ketelbey Issued 1,647,172 $0.044 $72,476 Issue of options
29/03/17 Geoffrey Brooke Buy +400,000 $0.066 $26,521 On-market trade
24/12/15 John (Bill) Ketelbey Buy +10,909 $0.058 $630 On-market trade
20/05/15 John (Bill) Ketelbey Issued 157,894 $0.095 $15,000 Participation in share purchase plan
20/05/15 Jason Loveridge Issued 157,894 $0.095 $15,000 Participation in share purchase plan
20/05/15 Anton Uvarov Issued 157,894 $0.095 $15,000 Participation in share purchase plan
20/05/15 Martin Rogers Issued 157,894 $0.095 $15,000 Participation in share purchase plan
01/12/14 Brendan de Kauwe Buy +2,500,000 $0.020 $50,000 Placement
01/12/14 Anton Uvarov Buy +2,000,000 $0.020 $40,000 Placement
12/12/13 Brendan de Kauwe Issued 2,000,000 $0.010 $20,000 Placement
12/12/13 Daniel Parasiliti Issued 1,000,000 $0.010 $10,000 Placement
Show All

Director Interests

The current holdings of ACW directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Geoffrey Brooke 27/11/2023 3,050,661 2,626,281 5,512,360 N/A
George Morstyn 27/11/2023 3,321,833 3,404,537 607,074 N/A
Steven Gourlay 11/09/2023 52,518,027 19,276,787 2,442,647 N/A
Malcolm McComas 11/09/2023 822,223 2,223,595 3,200,687 N/A
Nicki Vasquez 01/03/2023 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 3, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
HSBC Custody Nominees (Australia) Limited 250,917,257 13.82%
Dr Steven Gourlay 48,362,300 2.66%
Edinburgh Technology Fund Limited 48,147,864 2.65%
JSC Wealth Management Pty Ltd 44,655,962 2.46%
Citicorp Nominees Pty Limited 38,237,380 2.11%
Tisia Nominees Pty Ltd <Henderson Family A/C> 29,440,621 1.62%
Garnsworthy Pension Fund Pty Ltd <Garnsworthy Pension Fund A/C> 22,000,000 1.21%
Mr James Murch & Mrs Catherine Murch <MINJAL Super Fund A/C> 20,500,000 1.13%
Kaleidoscope Holdings Pty Ltd <Kaleidoscope Super A/C> 20,346,473 1.12%
SG Gourlay Nominees Pty Ltd <SF Gourlay Family A/C> 15,797,222 0.87%
Amber Court Nominees Pty Ltd <Min Min Light A/C> 15,023,401 0.83%
Iral Pty Ltd <IRAL A/C> 15,000,000 0.83%
Mrs Gillian Karen Nes & Mrs Ronald Nes <GIRO S/F A/C> 15,000,000 0.83%
Big Eater Pty Ltd <Brigitte Smith Family A/C> 12,999,659 0.72%
John Dahlsen Superannuation Fund Pty Ltd 12,900,000 0.71%
HSBC Custody Nominees (Australia) Limited – A/C 2 12,461,934 0.69%
Rickenbacker Capital Investments Pty Ltd 10,400,000 0.57%
Brazil Farming Pty Ltd 10,069,970 0.55%
Van Am Marketing Pty Ltd 10,000,854 0.55%
SVE Capital Pty Ltd <Strategic Vision Unit A/C> 10 0.59%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 119 296 592 2,258 1,456 4,721

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
BVF Partners L.P 15/09/2023 247,334,680 11.16

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.040 30 June
2022 $0.050 30 June
2021 $0.130 30 June
2020 $0.022 30 June
2019 $0.010 28 June
2018 $0.048 29 June
2017 $0.061 28 June
2016 $0.072 28 June
2015 $0.072 30 June
2014 $0.011 30 June
ACW Historical Price Data (CSV)
Up to 20 years of EOD share price history
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.